397 related articles for article (PubMed ID: 30912928)
1. Aryl Hydrocarbon Receptor and Uremic Toxins from the Gut Microbiota in Chronic Kidney Disease Patients: Is There a Relationship between Them?
Brito JS; Borges NA; Anjos JSD; Nakao LS; Stockler-Pinto MB; Paiva BR; Cardoso-Weide LC; Cardozo LFMF; Mafra D
Biochemistry; 2019 Apr; 58(15):2054-2060. PubMed ID: 30912928
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of tissue factor induction by the uremic toxin indole-3 acetic acid through aryl hydrocarbon receptor/nuclear factor-kappa B signaling pathway in human endothelial cells.
Addi T; Poitevin S; McKay N; El Mecherfi KE; Kheroua O; Jourde-Chiche N; de Macedo A; Gondouin B; Cerini C; Brunet P; Dignat-George F; Burtey S; Dou L
Arch Toxicol; 2019 Jan; 93(1):121-136. PubMed ID: 30324315
[TBL] [Abstract][Full Text] [Related]
3. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins.
Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D
Nephron; 2017; 137(1):1-7. PubMed ID: 28490014
[TBL] [Abstract][Full Text] [Related]
4. Resistant starch supplementation effects on plasma indole 3-acetic acid and aryl hydrocarbon receptor mRNA expression in hemodialysis patients: Randomized, double blind and controlled clinical trial.
Azevedo R; Esgalhado M; Kemp JA; Regis B; Cardozo LF; Nakao LS; Brito JS; Mafra D
J Bras Nefrol; 2020; 42(3):273-279. PubMed ID: 32459282
[TBL] [Abstract][Full Text] [Related]
5. Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway.
Gondouin B; Cerini C; Dou L; Sallée M; Duval-Sabatier A; Pletinck A; Calaf R; Lacroix R; Jourde-Chiche N; Poitevin S; Arnaud L; Vanholder R; Brunet P; Dignat-George F; Burtey S
Kidney Int; 2013 Oct; 84(4):733-44. PubMed ID: 23636172
[TBL] [Abstract][Full Text] [Related]
6. Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial.
Ramos CI; Armani RG; Canziani MEF; Dalboni MA; Dolenga CJR; Nakao LS; Campbell KL; Cuppari L
Nephrol Dial Transplant; 2019 Nov; 34(11):1876-1884. PubMed ID: 29939302
[TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease.
Dou L; Poitevin S; Sallée M; Addi T; Gondouin B; McKay N; Denison MS; Jourde-Chiche N; Duval-Sabatier A; Cerini C; Brunet P; Dignat-George F; Burtey S
Kidney Int; 2018 Apr; 93(4):986-999. PubMed ID: 29395338
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
[TBL] [Abstract][Full Text] [Related]
9. Tryptophan Metabolites Regulate Neuropentraxin 1 Expression in Endothelial Cells.
Vial R; Poitevin S; McKay N; Burtey S; Cerini C
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216489
[TBL] [Abstract][Full Text] [Related]
10. Indoxyl Sulfate Promotes Macrophage IL-1β Production by Activating Aryl Hydrocarbon Receptor/NF-κ/MAPK Cascades, but the NLRP3 inflammasome Was Not Activated.
Wakamatsu T; Yamamoto S; Ito T; Sato Y; Matsuo K; Takahashi Y; Kaneko Y; Goto S; Kazama JJ; Gejyo F; Narita I
Toxins (Basel); 2018 Mar; 10(3):. PubMed ID: 29543732
[TBL] [Abstract][Full Text] [Related]
11. From bench to the hemodialysis clinic: protein-bound uremic toxins modulate NF-κB/Nrf2 expression.
Stockler-Pinto MB; Soulage CO; Borges NA; Cardozo LFMF; Dolenga CJ; Nakao LS; Pecoits-Filho R; Fouque D; Mafra D
Int Urol Nephrol; 2018 Feb; 50(2):347-354. PubMed ID: 29151180
[TBL] [Abstract][Full Text] [Related]
12. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
[TBL] [Abstract][Full Text] [Related]
13. Can curcumin supplementation reduce plasma levels of gut-derived uremic toxins in hemodialysis patients? A pilot randomized, double-blind, controlled study.
Salarolli RT; Alvarenga L; Cardozo LFMF; Teixeira KTR; de S G Moreira L; Lima JD; Rodrigues SD; Nakao LS; Fouque D; Mafra D
Int Urol Nephrol; 2021 Jun; 53(6):1231-1238. PubMed ID: 33438085
[TBL] [Abstract][Full Text] [Related]
14. Is there an association between the plasma levels of uremic toxins from gut microbiota and anemia in patients on hemodialysis?
Capo-Chichi JCC; Borges NA; de Vargas Reis DCM; Nakao LS; Mafra D
Int Urol Nephrol; 2022 Jun; 54(6):1271-1277. PubMed ID: 34561817
[TBL] [Abstract][Full Text] [Related]
15. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease.
Sallée M; Dou L; Cerini C; Poitevin S; Brunet P; Burtey S
Toxins (Basel); 2014 Mar; 6(3):934-49. PubMed ID: 24599232
[TBL] [Abstract][Full Text] [Related]
16. Indoxyl glucuronide, a protein-bound uremic toxin, inhibits hypoxia-inducible factor‒dependent erythropoietin expression through activation of aryl hydrocarbon receptor.
Asai H; Hirata J; Watanabe-Akanuma M
Biochem Biophys Res Commun; 2018 Oct; 504(2):538-544. PubMed ID: 30205954
[TBL] [Abstract][Full Text] [Related]
17. Can Resveratrol Supplementation Reduce Uremic Toxin Plasma Levels From the Gut Microbiota in Nondialyzed Patients With Chronic Kidney Disease?
Alvarenga L; Cardozo LFMF; Leal VO; Kemp JA; Saldanha JF; Ribeiro-Alves M; Meireles T; Nakao LS; Mafra D
J Ren Nutr; 2022 Nov; 32(6):685-691. PubMed ID: 35122992
[TBL] [Abstract][Full Text] [Related]
18. Isolation and Quantification of Uremic Toxin Precursor-Generating Gut Bacteria in Chronic Kidney Disease Patients.
Gryp T; Huys GRB; Joossens M; Van Biesen W; Glorieux G; Vaneechoutte M
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183306
[TBL] [Abstract][Full Text] [Related]
19. Protein-Bound Uremic Toxins from Gut Microbiota and Inflammatory Markers in Chronic Kidney Disease.
Borges NA; Barros AF; Nakao LS; Dolenga CJ; Fouque D; Mafra D
J Ren Nutr; 2016 Nov; 26(6):396-400. PubMed ID: 27751361
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation.
Liu JR; Miao H; Deng DQ; Vaziri ND; Li P; Zhao YY
Cell Mol Life Sci; 2021 Feb; 78(3):909-922. PubMed ID: 32965514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
